Quality of care in diabetes: Understanding the guidelines

American Journal of the Medical Sciences

Volumn 324, Issue 4, 2002, Pages 196-206

  Bouldin, Marshall J ^a   Low, Annette K ^a   Blackston, Joseph W ^a   Duddleston, David N ^a   Holman, Honey E ^a   Hicks, G Swink ^a   Brown, C Andrew ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Guidelines; Quality indicators; Review

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PHENFORMIN; SULFONYLUREA; TOLBUTAMIDE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EPIDEMIC; EXERCISE; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANDEMIC; PATIENT EDUCATION; PRACTICE GUIDELINE; SELF CARE; SITTING;

EID: 0036788614     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200210000-00006     Document Type: Conference Paper

References (60)

1. National Diabetes Data Group. Diabetes in America. 2nd ed. NIH Publication no. 95-1468. Bethesda (MD): National Institutes of Health; 1995.
2. American Diabetes Association. Diabetes 1996 vital statistics. Alexandria (VA): American Diabetes Association; 1996.
3. Leese B. The costs of diabetes and its complications. Soc Sci Med 1992;35:1303-10.
4. Osler, W. Diabetes mellitus. In: The principles and practice of medicine. 2nd ed. New York: D. Appleton and Company; 1897. p. 320-9.
5. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. S. adults: the third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998;21:518-24.
6. Mokhad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1991-1998. Diabetes Care 2000;23:1278-83.
7. Rosenbloom AL, Joe JR, Young RS, et al. The emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22: 345-54.
8. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993;16:157-77.
9. American Diabetes Association. Diabetes mellitus and exercise (position statement). Diabetes Care 2001; 24(Suppl. 1):S51-5.
10. Thompson TG. Remarks by the HHS secretary Tommy G. Thompson at press conference announcing the results of the Diabetes Prevention Program. Washington (DC): United States Department of Health and Human Services; 2001 Aug 8.
11. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care 2001;24(Suppl. 1):S33-43.
12. Institute for Clinical Systems Integration. Clinical care guidelines: treatment of type 2 diabetes mellitus. Bloomington (MN): Institute for Clinical Systems Integration; 1998.
13. Jencks SF, Cuerdon T, Burwen DR. Quality of medical care delivered to medicare beneficiaries: a profile at state and national levels. JAMA 2000;284:1670-6.
14. Peters AL, Legorreta AO, Ossorio RC, et al. Quality of outpatient care provided to diabetic patients. Diabetes Care 1996;19:601-6.
15. O'Conner PJ, Pronk NP, Tan AWH, et al. Does professional advice influence aspirin use to prevent heart disease in an HMO population? Efficient Clin Pract 1998;1:26-32.
16. Streja DA, Rabkin SW. Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med 1999;159:294-302.
17. deleted in proof
18. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970;19(Suppl. 2):747-830.
19. American Diabetes Association. Implications of the United Kingdom prospective diabetes study (position statement). Diabetes Care 2001;24(Suppl. 1):S28-32.
20. Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
21. Reichard P, Nillsson BY, Rosenquist V. The effect of long-term intensified insulin treatment on the development of microvascular complications in diabetes mellitus. N Engl J Med 1993;329:304-9.
22. Okhubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
23. Abraira C, Colwell J, Nuttall F, et al. Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial: Veterans Affairs cooperative study on glycemic control and complications in type II diabetes. Arch Intern Med 1997;157:181-8.
24. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
25. Anonynmous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.
26. American Association of Clinical Endocrinologists. Clinical recommendations from the United Kingdom prospective diabetes study (UKPDS): commentary from the American Association of Clinical Endocrinologists (AACE). Endocr Pract 1999;5:157-8.
27. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317: 703-13.
28. Anonymous. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:713-20.
29. Anonymous. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
30. Ornstein SM, Jenkins RG. Quality of care for chronic illness in primary care: opportunity for improvement in process and outcome measures. Am J Manag Care 1999;5:621-7.
31. American Diabetes Association. Tests of glycemia in diabetes (position statement). Diabetes Care 2001;24(Suppl. 1): S80-2.
32. American Diabetes Association. Implications of the diabetes control and complications trial (position statement). Diabetes Care 2001;24(Suppl. 1):S25-7.
33. Pyorala K, Pedersen TR, Kjekshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetes patients with coronary heart disease. Diabetes Care 1997;20:614-20.
34. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
35. Schrier RW, Estacio RO, Jeffers B. Appropriate blood pressure control in NIDDM (ABCD trial). Diabetologica 1996; 39:646-54.
36. American Diabetes Association. Diabetic nephropathy (position statement). Diabetes Care 1998;21(suppl 1):S50-3.
37. Ravid M, Lang R, Rachmani R, et al. Long-term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study. Arch Intern Med 1996;156:286-9.
38. Sano T, Hotto N, Kawamura T, et al. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year prospective randomized study. Diabet Med 1996;13:120-4.
39. Anonymous. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796-806.
40. Anonynmous. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981;88:583-600.
41. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin dependent diabetes mellitus: a randomized controlled trial. Ann Intern Med 1993;119:36-41.
42. Bild DV, Selby JV, Sinnock P, et al. Lower extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care 1989;12:24-31.
43. American Diabetes Association. Preventive foot care in people with diabetes (position statement). Diabetes Care 2001;24(Suppl. 1):S56-7.
44. Sosenko JM, Kato K, Soto R, et al. Comparison of quantitative patients. Diabetes Care 1990;13:1056-61.
45. Anonymous. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.
46. Anonymous. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA 1992;268:1292-300.
47. Hanssen L, Zanchetti A, Carruthers SE, et al. Effects of intensive blood pressure lowering and low dose aspirin on patients with hypertension: principle results of the hypertension optimized treatment (HOT) randomized trial. Lancet 1998;351:1755-62.
48. American Diabetes Association. Aspirin therapy in diabetes (position statement). Diabetes Care 2001;24(Suppl. 1): S62-3.
49. Bartlett EE. Historical glimpses of patient education in the United States. Patient Educ Couns 1986;8:135-49.
50. Norris SL, Engeleau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24:561-87.
51. Niccoluci A, Cavaliere D, Scorpiglione N, et al. A comprehensive assessment of the avoidability of long-term complications of diabetes. Diabetes Care 1996;19:927-33.
52. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:S13-21.
53. Franz MJ, Monk A, Barry B, et al. Effectiveness of medical nutritional therapy provided by dieticians in the management of non-insulin-dependent diabetes mellitus: a randomized controlled clinical trial. J Am Diet Assoc 1995;95:1009-17.
54. Gagliardino JJ, Etchegoyen G. A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 2001;24:1001-7.
55. Vijan S, Stevens DL, Herman WH, et al. Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. J Gen Intern Med 1997;12:567-80.
56. Anonymous. National Standards for Diabetes Self-Management Education Programs. Task Force to Revise the National Standards. Diabetes Care 1995;18:141-4.
57. Physical activity and health: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, United States Department of Health and Human Services; 1996. Available at: URL: http://www.cdc.gov/nccdphp/sgr/sgr.htm
58. Lawler FH, Viviani N. Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Practice 1997;44:369-73.
59. Maly RC, Abrahamse AF, Hirsch SH, et al. What influences physician practice behavior? An interview study of physicians who received consultative geriatric assessment recommendations Arch Fam Med 1996;5:448-54.
60. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington (DC): National Academy Press; 1999.